Synthetic biology advances to generate $30B opportunity for Australia
A new report by CSIRO and Main Sequence Ventures charts Australia’s progress against ten recommendations put forward in the National Synthetic Biology Roadmap.
Stay updated with breaking news from Gabrielle Munzer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new report by CSIRO and Main Sequence Ventures charts Australia’s progress against ten recommendations put forward in the National Synthetic Biology Roadmap.
CSIRO and Main Sequence have released an updated roadmap showing synthetic biology (SynBio) could unlock over $30B in revenue and 50,000 new jobs for Australia by 2040.
Over the past couple of decades, Australia, an island continent of 26 million that became rich by, among other things, mining natural resources, has developed into a modern powerhouse that actively works to foster a dynamic tech and startup scene. To fully capitalize on that progress, Australian startups will have to overcome challenges like shortage of access to late-stage capital and a scarcity of executives with scale-up experience. Australia is shaped just as much by its peoples as it is by its industry.
This is part of a survey of investors focused on Australia and New Zealand. The following responses are from the Australian investors.
Raises $450 million in third funding round.